InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IGC Pharma, Inc.

IGC Clue Score54
United States Fiscal year ends December CIK 0001326205
$0.28 -1.76% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.28 −80.29% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.6Operating income−2.1Net income−1.9EPS, diluted−0.07Fiscal year 2018Revenue2.2 +277.9%Operating income−1.8Net income−1.8Fiscal year 2019Revenue5.1 +133.3%Operating income−4.6Net income−4.1Fiscal year 2020Revenue4.1 −20.4%Operating income−6.9Net income−7.3Fiscal year 2021Revenue0.9 −77.9%Operating income−8.7Net income−8.8Fiscal year 2022Revenue0.4 −55.8%Operating income−15.4Net income−15.0Fiscal year 2023Revenue0.9 +129.5%Operating income−11.6Net income−11.5Fiscal year 2024Revenue1.3 +47.6%Operating income−9.8Net income−13.0EPS, diluted−0.22Fiscal year 2025Revenue1.3 −5.5%Operating income−7.4Net income−7.1EPS, diluted−0.09
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.6 2.2 5.1 4.1 0.9 0.4 0.9 1.3 1.3
Growth +277.9% +133.3% −20.4% −77.9% −55.8% +129.5% +47.6% −5.5%
Operating income −2.1 −1.8 −4.6 −6.9 −8.7 −15.4 −11.6 −9.8 −7.4
Net income −1.9 −1.8 −4.1 −7.3 −8.8 −15.0 −11.5 −13.0 −7.1
Growth
EPS, diluted −0.07 n/a n/a n/a n/a n/a n/a −0.22 −0.09

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin37.6%Operating margin−354.0%Net margin−321.7%Free cash flow margin−264.8%Fiscal year 2018Gross margin3.7%Operating margin−81.6%Net margin−81.4%Free cash flow margin−94.3%Fiscal year 2019Gross margin2.6%Operating margin−90.8%Net margin−80.1%Free cash flow margin−65.4%Fiscal year 2020Gross margin2.8%Operating margin−168.6%Net margin−179.6%Free cash flow margin−320.9%Fiscal year 2021Gross margin12.6%Operating margin−971.5%Net margin−981.2%Free cash flow margin−1,366.4%Fiscal year 2022Gross margin48.9%Operating margin−3,886.1%Net margin−3,782.4%Free cash flow margin−1,939.0%Fiscal year 2023Gross margin48.5%Operating margin−1,270.1%Net margin−1,263.0%Free cash flow margin−807.6%Fiscal year 2024Gross margin54.5%Operating margin−728.5%Net margin−966.5%Free cash flow margin−396.8%Fiscal year 2025Gross margin48.7%Operating margin−585.8%Net margin−560.3%Free cash flow margin−386.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 37.6% 3.7% 2.6% 2.8% 12.6% 48.9% 48.5% 54.5% 48.7%
Operating margin −354.0% −81.6% −90.8% −168.6% −971.5% −3,886.1% −1,270.1% −728.5% −585.8%
Net margin −321.7% −81.4% −80.1% −179.6% −981.2% −3,782.4% −1,263.0% −966.5% −560.3%
Free cash flow margin −264.8% −94.3% −65.4% −320.9% −1,366.4% −1,939.0% −807.6% −396.8% −386.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−1.4Capital expenditure−0.1Free cash flow−1.5Fiscal year 2018Operating cash flow−1.9Capital expenditure−0.1Free cash flow−2.1Fiscal year 2019Operating cash flow−3.3Capital expenditure−0.0Free cash flow−3.3Fiscal year 2020Operating cash flow−8.7Capital expenditure−4.4Free cash flow−13.1Fiscal year 2021Operating cash flow−10.8Capital expenditure−1.5Free cash flow−12.3Fiscal year 2022Operating cash flow−7.5Capital expenditure−0.2Free cash flow−7.7Fiscal year 2023Operating cash flow−7.0Capital expenditure−0.3Free cash flow−7.4Fiscal year 2024Operating cash flow−5.2Capital expenditure−0.1Free cash flow−5.3Fiscal year 2025Operating cash flow−4.8Capital expenditure−0.1Free cash flow−4.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.4 −1.9 −3.3 −8.7 −10.8 −7.5 −7.0 −5.2 −4.8
Capital expenditure −0.1 −0.1 −0.0 −4.4 −1.5 −0.2 −0.3 −0.1 −0.1
Free cash flow −1.5 −2.1 −3.3 −13.1 −12.3 −7.7 −7.4 −5.3 −4.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.5Total debt0.5Net cash (debt)0.1Shareholders’ equity7.4Debt to equity0.06Fiscal year 2018Cash1.7Shareholders’ equity8.1Fiscal year 2019Cash25.6Shareholders’ equity33.6Fiscal year 2020Cash7.3Total debt0.0Net cash (debt)7.3Shareholders’ equity26.5Debt to equity0.00Fiscal year 2021Cash14.5Total debt0.3Net cash (debt)14.3Shareholders’ equity32.8Debt to equity0.01Fiscal year 2022Cash10.5Total debt0.1Net cash (debt)10.3Shareholders’ equity23.9Debt to equity0.01Fiscal year 2023Cash3.2Total debt0.1Net cash (debt)3.1Shareholders’ equity14.9Debt to equity0.01Fiscal year 2024Cash1.2Total debt0.1Net cash (debt)1.1Shareholders’ equity7.3Debt to equity0.02Fiscal year 2025Cash0.4Total debt0.1Net cash (debt)0.3Shareholders’ equity6.3Debt to equity0.02
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.5 1.7 25.6 7.3 14.5 10.5 3.2 1.2 0.4
Total debt 0.5 n/a n/a 0.0 0.3 0.1 0.1 0.1 0.1
Net cash (debt) 0.1 n/a n/a 7.3 14.3 10.3 3.1 1.1 0.3
Shareholders’ equity 7.4 8.1 33.6 26.5 32.8 23.9 14.9 7.3 6.3
Debt to equity 0.06 n/a n/a 0.00 0.01 0.01 0.01 0.02 0.02

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024† 31 Mar 2024 FY2025 31 Mar 2025
Revenue and profit
0.6 2.2 5.1 4.1 0.9 0.4 0.9 1.3 1.3
Growth +277.9% +133.3% −20.4% −77.9% −55.8% +129.5% +47.6% −5.5%
0.4 2.1 5.0 4.0 0.8 0.2 0.5 0.6 0.7
0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.7 0.6
Growth −62.4% +61.0% −12.9% −1.7% +71.7% +127.8% +65.8% −15.6%
n/a 0.1 1.3 1.0 0.9 2.3 3.5 3.8 3.7
2.3 1.7 3.5 6.0 7.9 13.3 8.6 6.8 4.4
−2.1 −1.8 −4.6 −6.9 −8.7 −15.4 −11.6 −9.8 −7.4
Growth
−1.8 −1.8 −4.1 −7.3 −8.8 −15.0 −11.5 −13.0 −7.1
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−1.9 −1.8 −4.1 −7.3 −8.8 −15.0 −11.5 −13.0 −7.1
Growth
Per share
−0.07 n/a n/a n/a n/a n/a n/a −0.22 −0.09
−0.07 n/a n/a n/a n/a n/a n/a −0.22 −0.09
Growth
25.7 27.9 35.4 39.5 42.0 50.0 52.6 58.8 76.5
25.7 n/a n/a n/a n/a n/a n/a 58.8 76.5
Growth +30.0%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 20.8% a year over five years.
  • Operating margin is down 417.3 points on five years ago, at -585.8%.
  • A net loss in 9 of 9 years on file.